The cellular pharmacology of methotrexate.
I D
ID
Goldman
L H
LH
Matherly
D000818:Animals; D000838:Anions; D001667:Binding, Competitive; D001693:Biological Transport, Active / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D003201:Computers; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004351:Drug Resistance; D005493:Folic Acid Antagonists; D006801:Humans; D066298:In Vitro Techniques; D002955:Leucovorin / Q000494:pharmacology; D008565:Membrane Proteins / Q000378:metabolism; D008727:Methotrexate / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D011099:Polyglutamic Acid / Q000378:metabolism; D013329:Structure-Activity Relationship; D013763:Tetrahydrofolates / Q000378:metabolism
D000838:Anions; D002352:Carrier Proteins; D005493:Folic Acid Antagonists; D008565:Membrane Proteins; D013763:Tetrahydrofolates; D011099:Polyglutamic Acid; D002955:Leucovorin; C011864:7-hydroxymethotrexate; D008727:Methotrexate